-
Needham & Company LLC Reaffirms "Buy" Rating for Inozyme Pharma (NASDAQ:INZY)
Source: Buzz FX / 06 Nov 2024 08:47:17 America/New_York
Needham & Company LLC Reaffirms "Buy" Rating for Inozyme Pharma (NASDAQ:INZY) Written by MarketBeat November 6, 2024 Share Link copied to clipboard. Inozyme Pharma ( NASDAQ:INZY - Get Free Report ) 's stock had its "buy" rating reiterated b
Read more...